The population distributions, upper normal limits and correlations between liver tests among Australian adolescents

Journal of Paediatrics and Child Health

Volumn 44, Issue 10, 2008, Pages 579-585

  George, Jacob ^a   Denney Wilson, Elizabeth ^b   Okely, Anthony D ^c   Hardy, Louise L ^b   Aitken, Robert ^d   Booth, Michael L ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

^d New South Wales Government   (Australia)

Author keywords

Adolescents; Liver tests; UNLs; Upper normal limits

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BODY MASS; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LIVER EXAMINATION; MAJOR CLINICAL STUDY; MALE; POPULATION DISTRIBUTION; PRIORITY JOURNAL;

ADOLESCENT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; AUSTRALIA; CLINICAL ENZYME TESTS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; REFERENCE VALUES;

EID: 52649138845     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2008.01386.x     Document Type: Article

References (14)

1. Lobstein T, Baur L, Uauy R. Obesity in children and young people: a crisis in public health. Obes. Rev. 2004 5 (Suppl. 1 4 104.
2. McCullough AJ. The epidemiology and risk factors of NASH. In : Farrell GC, George J, Hall P, McCullough AJ, eds. Fatty Liver Disease: NASH and Related Disorders. Malden, MA : Blackwell Publishing Ltd, 2005 23 37.
3. Jonas MM. Nonalcoholic fatty liver disease. Adolesc. Med. Clin. 2004 15 : 159 73.
4. Levine J, Schwimmer J. NAFLD/NASH in children. In : Farrell GC, George J, Hall P, McCullough AJ, eds. Fatty Liver Disease: NASH and Related Disorders. Boston, MA : Blackwell Publishing Ltd, 2005 229 40.
5. Booth ML, Okely AD, Denney-Wilson E, Hardy LL, Yang B, Dobbins T. NSW Schools Physical Activity and Nutrition Survey (SPANS) 2004: Full Report. Sydney : NSW Department of Health, 2006.
6. Booth ML, Denney-Wilson E, Okely AD, Hardy LL. Methods of the NSW Schools Physical Activity and Nutrition Survey (SPANS). J. Sci. Med. Sport 2005 8 : 284 93.
7. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. Br. Med. J. 2000 320 : 1240 3.
8. Piton A, Poynard T, Imbert-Bismut F et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology 1998 27 : 1213 9.
9. Prati D, Taioli E, Zanella A et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Intern. Med. 2002 137 : 1 9.
10. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al. CDC growth charts: United States. Adv. Data 2000 314 : 1 27.
11. American Academy of Pediatrics. National cholesterol education program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992 89 : 525 84.
12. Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 1997 20 : 537 44.
13. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001 344 : 1343 50.
14. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002 346 : 393 403.